Detalhe da pesquisa
1.
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?
Support Care Cancer
; 30(3): 2455-2465, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34779921
2.
Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis.
J Transl Med
; 19(1): 132, 2021 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33789686
3.
Heterogeneous disease and intermittent treatment in metastatic colorectal cancer: A case report.
Front Oncol
; 13: 1084681, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36814823
4.
Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer.
Nat Med
; 29(3): 605-614, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36864254
5.
Adjuvant chemotherapy after neoadjuvant chemo-radiotherapy and surgery in locally advanced rectal cancer. A systematic review of literature with a meta-analysis of randomized clinical trials.
Crit Rev Oncol Hematol
; 172: 103627, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35202817
6.
Retrospective Study of Regorafenib Versus TAS-102 Efficacy and Safety in Chemorefractory Metastatic Colorectal Cancer (mCRC) Patients: A Multi-institution Real Life Clinical Data.
Clin Colorectal Cancer
; 20(3): 227-235, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34226142
7.
Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol.
Ther Adv Med Oncol
; 13: 1758835921989223, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33854566
8.
Post-Induction Management in Patients With Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Treated With First-Line Anti-EGFR-Based Doublet Regimens: A Multicentre Study.
Front Oncol
; 11: 712053, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34778029
9.
Clinicians' Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients: A Multicenter, "Real-Life", Case-Control Study.
Clin Colorectal Cancer
; 20(4): 318-325, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34380594
10.
Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With RAS Wild-type Metastatic Colorectal Cancer: The Phase 2 Single-Arm Clinical CAVE Trial.
JAMA Oncol
; 7(10): 1529-1535, 2021 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34382998
11.
Baseline IFN-γ and IL-10 expression in PBMCs could predict response to PD-1 checkpoint inhibitors in advanced melanoma patients.
Sci Rep
; 10(1): 17626, 2020 10 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33077770
12.
Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania 'Luigi Vanvitelli'.
ESMO Open
; 5(2)2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32234730
13.
Evaluation of Second-line Anti-VEGF after First-line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter "SLAVE" Study.
Cancers (Basel)
; 12(5)2020 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-32429380
14.
Diagnostic value/performance of radiological liver imaging during chemoterapy for gastrointestinal malignancy: a critical review.
Acta Biomed
; 90(5-S): 51-61, 2019 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-31085973
15.
Atypical haemolytic-uraemic syndrome in patient with metastatic colorectal cancer treated with fluorouracil and oxaliplatin: a case report and a review of literature.
ESMO Open
; 4(5): e000551, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31673427
16.
A case report of a severe fluoropyrimidine-related toxicity due to an uncommon DPYD variant.
Medicine (Baltimore)
; 98(21): e15759, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31124962
17.
Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience.
Cancers (Basel)
; 11(10)2019 Oct 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31597339
18.
Clinical outcome of patients with chemorefractory metastatic colorectal cancer treated with trifluridine/tipiracil (TAS-102): a single Italian institution compassionate use programme.
ESMO Open
; 2(4): e000229, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29018575